TARS
Tarsus Pharmaceuticals Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Operating | |||||||
| Operating Cash Flow | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — |
| Investing | |||||||
| Capital Expenditures | 9.9M | 1.6M | 1.5M | 506,000 | 586,000 | 456,000 | 175,000 |
| Acquisitions | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — |
| Financing | |||||||
| Debt Repayment | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — |
| Summary | |||||||
| Free Cash Flow | -22.3M | -84.6M | -119.0M | -49.5M | 3.2M | -21.6M | -3.8M |
| Net Change in Cash | — | — | — | — | — | — | — |